Bavarian Nordic A/S

kr 241.00As of Sun 8 Nov 2026, 12:00 UTC
CPH:BAVAHealthcare
Country Denmark
PE (Fwd) •••
TSR 10Y CAGR 2.84%
Div yield —
ROE 12.21%
Biotechnology
Beta (5Y) 1.02
PE TTM 12.41
TSR TTM 0.84%
Mkt cap kr 18.25B
ROIC 8.30%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 238
(1.31%)
(95.45%)
Hold 11|4|8|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
3.05
3.22
3.48
3.50
34.20%
26.85%
35.79%
26.11%
Revenuekr B
1.100
1.131
1.183
1.233
11.27%
12.89%
12.66%
13.69%
Peers (US$2.720B)
Cap (US$)
PE
8.031B
39.82x
2.365B
6.044x
740.4M
—
2.722B
—
Capital
TTM
5Y
10Y
Leveragex
0.120
0.379
0.303
EBIT/Intx
1.116
0.362
0.368
Own earn%
(91.77)
(128.13)
(120.43)
Sh yield%
21.87
38.85
36.45
Owners
Insiders/Inst%
7.98
56.16
Short interest%
3.14
SBC / revenue%
2.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
6–13
$1 testx
—
Incr. ROIC%
4